NSPR InspireMD Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: NSPR

Price (delayed)

$0.9102

Market cap

$42.63M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.71

Enterprise value

$33.31M

?
Relative Growth: Rel. Growth: 72
Relative Strength: Rel. Strength: 3
Relative Valuation: Rel. Valuation: 10
Relative Profitability: Rel. Profitability: 7

InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, ...

Highlights
InspireMD's gross profit has soared by 102% YoY and by 15% from the previous quarter
NSPR's revenue has soared by 54% year-on-year and by 21% since the previous quarter
InspireMD's equity has soared by 54% YoY but it has decreased by 21% from the previous quarter
NSPR's gross margin is up by 31% year-on-year but it is down by 4.7% since the previous quarter
InspireMD's net income has decreased by 42% YoY and by 5% from the previous quarter
Sector: Healthcare
Industry: Medical Devices
Website: http://www.inspiremd.com
Peers: ABT MDT ISRG SYK

Key stats

What are the main financial stats of NSPR

NSPR stock price

How has the InspireMD stock price performed over time
Intraday
-5.2%
1 week
1.13%
1 month
-22.21%
1 year
-64.99%
YTD
-48.87%
QTD
-44.16%

Financial performance

How have InspireMD's revenue and profit performed over time
Revenue
$10.85M
Gross profit
$3.04M
Operating income
-$52.13M
Net income
-$51.31M
Gross margin
28.1%
Net margin
-473%
InspireMD's gross profit has soared by 102% YoY and by 15% from the previous quarter
NSPR's revenue has soared by 54% year-on-year and by 21% since the previous quarter
InspireMD's net income has decreased by 42% YoY and by 5% from the previous quarter
The operating income is down by 39% YoY and by 5% QoQ

Price vs fundamentals

How does NSPR's price correlate with its fundamentals

Growth

What is InspireMD's growth rate over time

Valuation

What is InspireMD stock price valuation
P/E
N/A
P/B
0.98
P/S
7.03
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
3.07
InspireMD's EPS has increased by 9% YoY and by 7% QoQ
InspireMD's equity has soared by 54% YoY but it has decreased by 21% from the previous quarter
The price to book (P/B) is 49% lower than the last 4 quarters average of 2.0 and 21% lower than the 5-year quarterly average of 1.3
NSPR's revenue has soared by 54% year-on-year and by 21% since the previous quarter
The P/S is 54% lower than the last 4 quarters average of 16.1 and 34% lower than the 5-year quarterly average of 11.3

Efficiency

How efficient is InspireMD business performance
The ROE has contracted by 18% YoY but it has grown by 3.6% from the previous quarter
InspireMD's return on invested capital has decreased by 17% YoY but it has increased by 11% QoQ
The company's return on assets fell by 14% YoY but it rose by 2.7% QoQ
InspireMD's return on sales has increased by 13% QoQ and by 8% YoY

Dividends

What is NSPR's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for NSPR.

Financial health

How did InspireMD financials performed over time
NSPR's total assets is up by 46% year-on-year but it is down by 19% since the previous quarter
The total liabilities is up by 24% year-on-year but it has declined by 9% since the previous quarter
NSPR's debt is 95% smaller than its equity
InspireMD's equity has soared by 54% YoY but it has decreased by 21% from the previous quarter
InspireMD's debt to equity has increased by 25% from the previous quarter but it has decreased by 17% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.